Biological activity of histamine and pharmacological profile of antihistamines used in dermatology;Attività biologica dell'istamina e profilo farmacologico degli antistaminici usati in dermatologia

Annali Italiani di Dermatologia Allergologica Clinica e Sperimentale

Volumn 54, Issue 3, 2000, Pages 121-134

  Cassano, N ^a   Amoruso, A ^a   Nettis, E ^a   Calsolaro, M ^a   Vena, G A ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Antihistamines; Antiinflammatory antiallergic effects; Histamine; Pharmacokinetics; Tolerability

Indexed keywords

ACRIVASTINE; ADRENALIN; ALIMEMAZINE; ALIPHATIC AMINE; ANTIHISTAMINIC AGENT; ASTEMIZOLE; CETIRIZINE; CLEMASTINE; CYPROHEPTADINE; DIPHENHYDRAMINE; DOXYLAMINE; ETHANOLAMINE DERIVATIVE; ETHYLENEDIAMINE DERIVATIVE; FEXOFENADINE; HISTAMINE; HISTAMINE RECEPTOR; LORATADINE; MIZOLASTINE; OXATOMIDE; OXYGEN RADICAL; PHENINDAMINE; PHENIRAMINE; PHENOTHIAZINE DERIVATIVE; PHENYLTOLOXAMINE; PIPERAZINE DERIVATIVE; PIPERIDINE DERIVATIVE; PROMETHAZINE; TERFENADINE; TRIMETHOBENZAMIDE; UNINDEXED DRUG;

ALLERGY; CARDIOTOXICITY; DROWSINESS; DRUG MECHANISM; HUMAN; NONHUMAN; REVIEW;

EID: 0034478150     PISSN: 0365169X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. Autacoids: Drug therapy of inflammation
2. Inflammation
3. The new H1 antihistamines: Treatment of urticaria and other clinical problems
4. Molecular properties and signalling pathways of the histamine H1 receptor
5. Does intracellular histamine mediate mast cell histamine release?
6. Histamine as an intracellular messenger
7. Functional characteristics of histamine receptor-bearing mononuclear cells. II. Identification of characterisation of two histamine-induced lymphokines that inhibit lymphocyte migration
8. Histamine: An early messenger in inflammatory and immune reactions
9. Cimetidine as an immunomodulator in the treatment of herpes zoster
10. Cimetidine: An immunomodulator
11. Treatment of molluscum contagiosum with oral cimetidine: Clinical experience in 13 patients
12. Cimetidine therapy for recalcitrant warts in adults
13. Inefficacy of oral cimetidine for nonatopic children with molluscum contagiosum
14. Cimetidine therapy for warts: A placebo-controlled, double-blind study
15. Hormonal changes and hair growth during treatment of hirsutism with cimetidine
16. Treatment of female androgenetic alopecia with cimetidine
17. Successful treatment of chronic idiopathic urticaria and angioedema with cimetidine alone
18. Combined H1 and H2 antihistamine therapy in chronic urticaria
19. Treatment of chronic urticaria with terfenadine and ranitidine: A randomized double-blind study in 45 patients
20. Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: A multi-centre randomized double-blind study
21. Cimetidine increases the plasma concentration of hydroxyzine
22. Greater inhibition of dermographism with combination of H1 and H2 antagonists
23. The effect of H1 and H2 histamine antagonists on symptomatic dermographism
24. Histamine2 (H2)-receptor antagonists in the treatment of urticaria
25. The clinical safety of H1 receptor antagonists: An EAACI position paper
26. Why are non-sedating antihistamines non-sedating?
27. Pharmacologic therapy for urticaria
28. Pharmacology and toxicology of non-classical antihistamines
29. Treatment of urticaria and angioedema: Low-sedating H1-type antihistamines
30. Advancements in antiallergic therapy: Beyond conventional antihistamines
31. Antihistamines
32. H1-receptor antagonists: Does a dose-response relationship exist?
33. Pharmacological characteristics of second-generation H1-blockers
34. Non-H1-receptor effects of antihistamines
35. Urticaria: New therapeutic approaches
36. Mechanism of action of antipruritic drugs
37. Oxatomide: A review of its pharmacodynamic properties and therapeutic efficacy
38. Ketotifen: A review of its therapeutic efficacy in dermatological disorders
39. Ketotifen: A review of its pharmacodynamic and pharmacocinetic properties, and therapeutic use in asthma and allergic disorders
40. Prevention of mast-cell degranulation by ketotifen in patients with physical urticarias
41. Ketotifen in the treatment of atopic dermatitis: Results of a double blind study
42. Sequential therapy with nimesulide and ketotifen in delayed pressure urticaria
43. Mizolastine: Antihistaminic activity from preclinical data to clinical evaluation
44. Evolution of H1-receptor antagonists treatment
45. The systemic safety of fexofenadine HCl
46. Antihistamines and aircrew: Usefulness of fexofenadine
47. Appraisal of the validity of histamine-induced wheal and flare to predict the clinical efficacy of antihistamines
48. Blockade of cardiac potassium and other channels by antihistamines
49. Arrhythmogenic mechanisms of non-sedating antihistamines
50. Cardiovascular safety of fexofenadine HCl
51. QT interval monitoring during clinical studies with mizolastine, a new H1 antihistamine
52. A review of the cardiac systemic side-effects of antihistamines: Ebastine
53. Cardiovascular profile of loratadine
54. Electrophysiological effects of cetirizine, astenmizole and D-sotalol in a canine model of long QT syndrome
55. QT lengthening and life-threatening arrhythmias associated with fexofenadine
56. QT lengthening and arrhythmias associated with fexofenadine
57. Fexofenadine-induced QT prolongation: A myth or fact?
58. QT lengthening and life-threatening arrhythmias associated with fexofenadine
59. Cardiovascular safety of fexofenadine HCl
60. Preclinical in vitro cardiac electrophysiology: A method of predicting arrhythmogenic potential of antihistamines in humans?
61. Dermatologic drugs in pregnancy
62. Dermatologic drugs, pregnancy, and lactation: A conservative guide
63. Antihistaminiques et grossesse
64. Prospective controlled study of hydroxyzine and cetirizine in pregnancy
65. Terfenadine (Seldane) exposure in early pregnancy
66. Pregnancy outcome after gestational exposure to terfenadine: A multicenter, prospective controlled study
67. Treating allergic rhinitis in pregnancy: Safety considerations
68. Enhanced cancer growth in mice administered daily humans-equivalent doses of some H1 antihistamines: Predictive in vitro correlates
69. Non-H1-receptor effects of antihistamines
70. Effects of antihistamines on inflammatory mediators
71. Efficacy and safety of antihistamines in allergic skin disorders
72. Effect of cetirizine on mast cell-mediator release and cellular traffic during late-phase reactions
73. Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo
74. Terfenadine, an antihistamine, inhibits histamine release in vivo in the human
75. Antiinflammatory effects of oxatomide
76. Inhibitory effect of oxatomide on oxygen-radical generation and peptide-leukotriene release from guinea pig eosinophils
77. Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines
78. Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis
79. Effects of H1 antihistamines on adhesion molecules: A possible rationale for long-term treatment
80. Beyond the histamine receptor: Effect of antihistamines on mast cells
81. H1-receptor antagonists: Effects on leukocytes, mith or reality?
82. Anti-inflammatory properties of nuzolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat
83. Antiallergic activities of antihistamines
84. Anti-inflammatory action of histamine H1-receptor antagonists unrelated to H1-receptor blockade
85. Adhesion molecules of allergic inflammation: Recent insights into their functional roles